We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZDGE icon
10651
Zedge
ZDGE
$38.4M
$190K ﹤0.01%
65,970
+33,058
+100% +$163K
PRTY
10652
PUT
DELISTED
Party City Holdco Inc.
PRTY
$190K ﹤0.01%
144,000
+14,900
+12% +$33K
MBAC.WS
10653
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$190K ﹤0.01%
1,897,714
-48,875
-3% -$11.9K
BAK icon
10654
Braskem
BAK
$777M
$189K ﹤0.01%
13,227
-20,079
-60% -$344K
CLPR
10655
PUT
Clipper Realty
CLPR
$54M
$189K ﹤0.01%
24,500
-8,100
-25% -$69.5K
MCS icon
10656
PUT
Marcus Corp
MCS
$925M
$189K ﹤0.01%
12,800
-10,200
-44% -$157K
NVGS icon
10657
PUT
Navigator Holdings
NVGS
$1.29B
$189K ﹤0.01%
16,700
-17,000
-50% -$220K
ONB icon
10658
CALL
Old National Bancorp
ONB
$10.4B
$189K ﹤0.01%
+12,776
New +$197K
GERN icon
10659
CALL
Geron
GERN
$943M
$188K ﹤0.01%
121,000
-9,200
-7% -$13K
KREF
10660
PUT
KKR Real Estate Finance Trust
KREF
$490M
$188K ﹤0.01%
10,800
-2,900
-21% -$55.9K
RITM icon
10661
Rithm Capital
RITM
$5.79B
$188K ﹤0.01%
20,162
-234,461
-92% -$2.46M
WIMI
10662
CALL
WiMi Hologram Cloud
WIMI
$25M
$188K ﹤0.01%
8,680
-10
-0.1% -$208
XOVR
10663
EntrepreneurShares Series Trust ERShares Private-Public Crossover ETF
XOVR
$1.89B
$188K ﹤0.01%
19,930
+3,696
+23% +$38.8K
HYZN
10664
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$188K ﹤0.01%
1,281
+435
+51% +$92.2K
TCRR
10665
CALL
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$188K ﹤0.01%
+64,700
New +$160K
ACQRW
10666
DELISTED
Independence Holdings Corp. Warrant
ACQRW
$188K ﹤0.01%
894,700
-35,300
-4% -$11.8K
KNDI
10667
Kandi Technologies Group
KNDI
$63M
$187K ﹤0.01%
78,013
-36,714
-32% -$95.4K
MDXG icon
10668
CALL
MiMedx Group
MDXG
$622M
$187K ﹤0.01%
53,900
+8,700
+19% +$34.1K
MITK icon
10669
Mitek Systems
MITK
$877M
$187K ﹤0.01%
20,230
-4,443
-18% -$47.3K
TYO icon
10670
Direxion Daily 7-10 Year Treasury Bear 3X ETF
TYO
$11.7M
$187K ﹤0.01%
+16,309
New +$187K
VNDA icon
10671
CALL
Vanda Pharmaceuticals
VNDA
$316M
$187K ﹤0.01%
17,200
-3,300
-16% -$34.2K
PSTX
10672
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$187K ﹤0.01%
72,574
+54,437
+300% +$151K
ACH
10673
DELISTED
Alum Corp of China Ltd
ACH
$187K ﹤0.01%
19,709
+8,866
+82% +$101K
FST
10674
CALL
DELISTED
FAST Acquisition Corp.
FST
$187K ﹤0.01%
18,500
-14,100
-43% -$142K
AMRX icon
10675
CALL
Amneal Pharmaceuticals
AMRX
$6.32B
$186K ﹤0.01%
58,400
+21,700
+59% +$78.6K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.